Abstract
The factors, influencing the development of cognitive defects in patients after chemotherapy are the following: personal individual intellectual and genetic characteristics, immune dysfunction and neurotoxicity. Cognitive domains, disturbed to a greater extent, are memory, attention, thinking rate and executive functions. Sixty one patients, diagnosed lymphoproliferative disease, (chronic lympholeukosis – 28 persons, multiple myeloma – 33) were examined; patients’ mean age was 63.87 ± 9.76 years. Reduced cognitive function was revealed in 73.77 % of patients, a mean score by MoCA scale was 22.87 ± 4.08. Cognitive defects negatively influence patients’ quality of life, significantly reduce their physical and mental working ability, everyday activity, make execution of professional duties difficult, besides they can complicate nursing.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
